457 related articles for article (PubMed ID: 1391015)
1. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
Sánchez C; Armengol R; Mir I; Lite J; Garau J
Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
[TBL] [Abstract][Full Text] [Related]
2. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
3. [Current use of penicillin in community-acquired pneumococcal pneumonias].
Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
[TBL] [Abstract][Full Text] [Related]
4. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap?
Wiener-Well Y; Raveh D; Schlesinger Y; Yinnon AM; Rudensky B
Chemotherapy; 2009; 55(2):97-104. PubMed ID: 19145079
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
[TBL] [Abstract][Full Text] [Related]
7. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F
N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF
N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pneumococcal pneumonia.
Pallares R
Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
[TBL] [Abstract][Full Text] [Related]
11. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
[TBL] [Abstract][Full Text] [Related]
12. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients.
Gentile JH; Sparo MD; Mercapide ME; Luna CM
Medicina (B Aires); 2003; 63(1):9-14. PubMed ID: 12673954
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
Frick PA; Black DJ; Duchin JS; Deliganis S; McKee WM; Fritsche TR
West J Med; 1998 Dec; 169(6):364-9. PubMed ID: 9866434
[TBL] [Abstract][Full Text] [Related]
17. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
[TBL] [Abstract][Full Text] [Related]
20. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
